Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2022 | 11-2021 | 08-2021 | 05-2021 | 02-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,772 | -2,668 | -1,543 | -7,446 | -5,735 |
| Depreciation Amortization | 292 | 195 | 98 | 376 | 269 |
| Accounts receivable | 1,113 | 1,140 | 778 | -456 | -691 |
| Other Working Capital | 5,844 | 3,886 | 1,116 | -1,853 | -1,816 |
| Other Operating Activity | -701 | -1,133 | -373 | 4,127 | 3,729 |
| Operating Cash Flow | $3,777 | $1,419 | $76 | $-5,252 | $-4,244 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -18 | -5 | -136 | -107 |
| Purchase Sale Intangibles | -113 | -109 | -72 | -160 | -117 |
| Other Investing Activity | -114 | -109 | -72 | -160 | -117 |
| Investing Cash Flow | $-146 | $-127 | $-78 | $-296 | $-224 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,441 | 1,786 | 842 | 1,280 | 1,108 |
| Other Financing Activity | -85 | -67 | -38 | -166 | 0 |
| Financing Cash Flow | $2,356 | $1,719 | $805 | $1,114 | $1,108 |
| Exchange Rate Effect | -13 | -10 | -6 | -8 | -9 |
| Beginning Cash Position | 4,199 | 4,199 | 4,199 | 8,641 | 8,641 |
| End Cash Position | 10,174 | 7,199 | 4,997 | 4,199 | 5,273 |
| Net Cash Flow | $5,975 | $3,000 | $797 | $-4,442 | $-3,369 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,777 | 1,419 | 76 | -5,252 | -4,244 |
| Capital Expenditure | -33 | -18 | -5 | -136 | -107 |
| Free Cash Flow | 3,745 | 1,401 | 71 | -5,388 | -4,351 |